Kim Popovits

Ms. Popovits brings over 40 years of experience in the healthcare industry, most recently serving as President and Chief Executive Officer of Genomic Health from 2009, and as Chairman of the Board of Genomic Health from 2012. Prior to those roles, Ms. Popovits served as President and Chief Operating Officer of Genomic Health from 2002 to 2009. From 1987 to 2002, Ms. Popovits served in various roles at Genentech, Inc., most recently serving as Senior Vice President, Marketing and Sales from 2001 to 2002, and as Vice President, Sales from 1994 to 2001.

Ms. Popovits has served on the board of directors of Kiniksa Pharmaceuticals, Ltd. since 2018, 10x Genomics, Inc. since 2020 and Talis Biomedical Corporation since 2020, where she also served as interim Chief Executive Officer from August 2021 to November 2021. Ms. Popovits previously served on the board of directors of MyoKardia, Inc. from 2017 to 2020, ZS Pharma Inc. in 2015, and Nuvelo, Inc. from 2005 to 2009. She holds a B.A. in Business from Michigan State University.